Project Details
Description
I4V-MC-JAIA(a): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus
| Status | Active |
|---|---|
| Effective start/end date | 5/1/19 → 5/31/24 |
Funding
- ELI LILLY AND COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.